Article Text

Download PDFPDF

Rationale and protocol for using a smartphone application to study autism spectrum disorders: SMARTAUTISM
  1. Olivier Bonnot1,
  2. Dominique Bonneau2,
  3. Aude Doudard3,4,
  4. Philippe Duverger3,4
  1. 1Child and Adolescent Psychiatry Department, University Hospital of Nantes, Nantes, France
  2. 2Department of Biochemistry and Genetics, CHU Angers, Angers, France
  3. 3Resource Center for Autism (CRA) Loire Valley, CHU Angers, Angers, France
  4. 4Psychiatry and Adolescent Department, CHU Angers, Angers, France
  1. Correspondence to Professor Olivier Bonnot; olivier.bonnot{at}gmail.com

Abstract

Introduction Longitudinal studies on the evolution of autism spectrum disorder (ASD) symptoms are limited and have primarily used repeated measurements performed several months apart. However, measurements of changes in everyday life should more closely reflect the ‘real life’ of the patient and his or her family. We propose to study the child's ASD symptoms and their effect on the quality of life, psychological status and anxiety of the child's parents over a 6-month period using SMARTAUTISM, a smartphone application.

Method and analysis This is a prospective, longitudinal, exploratory, open study with a 6-month follow-up period. Data will be recorded longitudinally over multiple weeks under natural conditions. The factors affecting the quality of life and anxiety of parents of children with ASD and the children's functional symptoms will be examined, and the feasibility of using a smartphone application designed for parents of ASD patients will be assessed. Primary objective: Explore the evolution of a child's behaviour over 6 months and the (psychological and social) effects of these changes on the family. Secondary objective: Assess the feasibility of our application by examining the filling rate and application usage by parents for 6 months. 100 families containing 1 child diagnosed with ASD will be included. At baseline, sociodemographic, psychiatric and medical data will be recorded. The correlations of the general epidemiological variables (primary outcome measure) will be evaluated via multivariate analysis. The application filling rate (relative to the ideal filling rate) will be used to assess the feasibility of the application (secondary outcome measure).

Ethics and dissemination The SMARTAUTISM study has the approval of the local ethics committee, and data security will be ensured via the use of encryption and a secure medical server. The use of this application will be proposed at autism resource centres across France.

  • Autism Spectrum Disorders
  • Quality of Life
  • Smartphone Application
  • Ecological Momentary Assessment

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors OB, DB, PD and AD were involved in the conception and design of the study. OB drafted the article, DB, PD and AD revised it critically for important intellectual content. The figures were prepared by AD and OB. OB, DB, AD and PD were involved in the conception of the smartphone application. All authors gave final approval of the version to be published.

  • Funding Institut de Recherche en Epidémiologie et Santé Publique. Caisse Nationale de Solidarité pour l'Autonomie. Centre Ressource Autisme des Pays de la Loire.

  • Competing interests None declared.

  • Ethics approval Comité de Protection des Personnes en Recherche Biomédicales des Rennes.

  • Provenance and peer review Not commissioned; externally peer reviewed.